Actinogen Medical Current Valuation vs. Profit Margin
| ACW Stock | 0.03 0 6.90% |
For Actinogen Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Actinogen Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Actinogen Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Actinogen Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Actinogen Medical over time as well as its relative position and ranking within its peers.
Actinogen |
Actinogen Medical Profit Margin vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Actinogen Medical's current stock value. Our valuation model uses many indicators to compare Actinogen Medical value to that of its competitors to determine the firm's financial worth. Actinogen Medical is the top company in current valuation category among its peers. It is rated third in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Actinogen Medical's earnings, one of the primary drivers of an investment's value.Actinogen Current Valuation vs. Competition
Actinogen Medical is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 340.91 Billion. Actinogen Medical adds roughly 80.11 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Actinogen Profit Margin vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Actinogen Medical |
| = | 80.11 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Actinogen Medical |
| = | (1.31) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Actinogen Profit Margin Comparison
Actinogen Medical is currently under evaluation in profit margin category among its peers.
Actinogen Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Actinogen Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Actinogen Medical will eventually generate negative long term returns. The profitability progress is the general direction of Actinogen Medical's change in net profit over the period of time. It can combine multiple indicators of Actinogen Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.4 M | 1.3 M | |
| Operating Income | -12.8 M | -12.2 M | |
| Income Before Tax | -23 M | -21.8 M | |
| Total Other Income Expense Net | -10.1 M | -9.6 M | |
| Net Loss | -13 M | -12.4 M | |
| Income Tax Expense | -9.9 M | -9.4 M | |
| Net Loss | -13 M | -12.4 M | |
| Net Loss | -9.7 M | -9.2 M | |
| Interest Income | 291 K | 305.6 K | |
| Net Interest Income | 266.7 K | 280.1 K | |
| Change To Netincome | 1.7 M | 1.8 M |
Actinogen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Actinogen Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Actinogen Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Actinogen Medical's important profitability drivers and their relationship over time.
Use Actinogen Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actinogen Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will appreciate offsetting losses from the drop in the long position's value.Actinogen Medical Pair Trading
Actinogen Medical Pair Trading Analysis
The ability to find closely correlated positions to Actinogen Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Actinogen Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Actinogen Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Actinogen Medical to buy it.
The correlation of Actinogen Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Actinogen Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Actinogen Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Actinogen Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Actinogen Medical position
In addition to having Actinogen Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Commodities ETFs Thematic Idea Now
Broad Commodities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.